| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/18/2023 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 5k | $10.73 | $53.4k | | 08/17/2023 |
| 08/17/2023 | KalVista Pharmaceuticals, Inc. | KALV | Exercise | Restricted Stock Unit | 1.8k | $0.00 | $0 | | 08/17/2023 |
| 08/17/2023 | KalVista Pharmaceuticals, Inc. | KALV | Exercise | Restricted Stock Unit | 2.4k | $0.00 | $0 | | 08/17/2023 |
| 08/17/2023 | KalVista Pharmaceuticals, Inc. | KALV | Exercise | Performance Stock Unit | 7.3k | $0.00 | $0 | | 08/17/2023 |
| 05/18/2023 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 1.8k | $10.14 | $18.1k | | 01/11/2023 |
| 05/17/2023 | KalVista Pharmaceuticals, Inc. | KALV | Exercise | Restricted Stock Unit | 2.4k | $0.00 | $0 | | 01/11/2023 |
| 05/17/2023 | KalVista Pharmaceuticals, Inc. | KALV | Exercise | Restricted Stock Unit | 1.8k | $0.00 | $0 | | 01/11/2023 |
| 02/17/2023 | KalVista Pharmaceuticals, Inc. | KALV | Exercise | | 2.4k | $0.00 | $0 | | 02/17/2023 |
| 02/17/2023 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 2.2k | $7.66 | $17.1k | | 02/17/2023 |
| 02/17/2023 | KalVista Pharmaceuticals, Inc. | KALV | Exercise | Performance Restricted Stock Unit | 2.4k | $0.00 | $0 | | 02/17/2023 |
| 02/17/2023 | KalVista Pharmaceuticals, Inc. | KALV | Exercise | Restricted Stock Unit | 1.8k | $0.00 | $0 | | 02/17/2023 |
| 01/11/2023 | KalVista Pharmaceuticals, Inc. | KALV | Grant | Restricted Stock Unit | 29.2k | $0.00 | $0 | | 01/11/2023 |
| 11/18/2022 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 530 | $5.44 | $2.9k | | 11/17/2022 |
| 11/17/2022 | KalVista Pharmaceuticals, Inc. | KALV | Exercise | Restricted Stock Unit | 1.8k | $0.00 | $0 | | 11/17/2022 |
| 08/17/2022 | KalVista Pharmaceuticals, Inc. | KALV | Exercise | Restricted Stock Unit | 1.8k | $0.00 | $0 | | 08/17/2022 |
| 08/17/2022 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 532 | $14.96 | $8k | | 08/17/2022 |
| 01/07/2022 | KalVista Pharmaceuticals, Inc. | KALV | Exercise | Employee Stock Option (right to buy) | 23.9k | $8.21 | $195.9k | | 01/07/2022 |
| 01/07/2022 | KalVista Pharmaceuticals, Inc. | KALV | Exercise | Employee Stock Option (right to buy) | 33.8k | $7.07 | $239k | | 01/07/2022 |
| 11/01/2021 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 6k | $18.07 | $108.4k | | 11/01/2021 |
| 08/02/2021 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 6k | $20.52 | $123.1k | | 08/02/2021 |
| 06/02/2021 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 7.1k | $26.33 | $188k | | 06/01/2021 |
| 06/02/2021 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 1.1k | $27.05 | $28.7k | | 06/01/2021 |
| 06/01/2021 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 25.8k | $26.81 | $691.3k | | 06/01/2021 |
| 06/01/2021 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 14 | $27.21 | $381 | | 06/01/2021 |
| 05/26/2021 | KalVista Pharmaceuticals, Inc. | KALV | Grant | Employee Stock Option (Right to Buy) | 60k | $25.95 | $1.6M | | 05/26/2021 |
| 05/03/2021 | KalVista Pharmaceuticals, Inc. | KALV | Exercise | Employee Stock Option (right to buy) | 6k | $10.21 | $61.3k | | 05/03/2021 |
| 05/03/2021 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 6k | $24.84 | $149.1k | | 05/03/2021 |
| 05/03/2021 | KalVista Pharmaceuticals, Inc. | KALV | Sale | | 6k | $24.84 | $149.1k | | 05/03/2021 |
| 02/23/2021 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 800 | $31.73 | $25.4k | | 02/23/2021 |
| 02/23/2021 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 5.5k | $32.97 | $180.4k | | 02/23/2021 |
| 02/23/2021 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 23.4k | $33.72 | $790.5k | | 02/23/2021 |
| 02/23/2021 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 1.3k | $35.19 | $45.3k | | 02/23/2021 |
| 02/07/2021 | KalVista Pharmaceuticals, Inc. | KALV | Grant | Stock Option (right to buy) | 22.5k | $24.23 | $545.2k | | 02/07/2021 |
| 02/07/2021 | KalVista Pharmaceuticals, Inc. | KALV | Grant | Stock Option (right to buy) | 20k | $10.20 | $204k | | 02/07/2021 |
| 02/07/2021 | KalVista Pharmaceuticals, Inc. | KALV | Grant | Common Stock | 12.5k | $0.00 | $0 | | 02/07/2021 |
|